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SUMMARY
Estimation of kidney function by measuring serum
creatinine is one the commonest laboratory tests
conducted in clinical practice. Enzymatic methods are
often used to measure serum creatinine. Clinicians
should be aware of the limitations of these methods,
such as test interference with paraproteins.We present a
case of falsely elevated serum creatinine in a patient
referred for renal biopsy. The combination of ﬂuctuating
creatinine and normal blood urea level was unusual.
Serum protein electrophoresis revealed the presence of
an IgM paraprotein. Further investigations conﬁrmed an
underlying diagnosis of lymphoplasmacytoid lymphoma.
This case highlights how IgM paraprotein can interfere
with creatinine estimation by enzymatic assay and the
utility of alternative methods of estimating serum
creatinine.
BACKGROUND
It is important to question the validity of the test
used if results are inconsistent or conﬂicting with
clinical and other laboratory ﬁndings.
Clinicians should be familiar with the method
used to measure serum creatinine at their local
laboratory and should be aware of alternative tests
to measure kidney function. Jaffé method which is
based on reaction of creatinine with picric acid is a
commonly used for creatinine measurement but
large number of substances can interfere with this
method including bilirubin, acetoacetate and
various drugs.1
Newer enzymatic tests such as Siemens Advia
enzymatic assay are thought to be more speciﬁc but
they are also subject to interference as we demon-
strated in this case, also here, unravelling the cause
of test interference helped towards making the
right diagnosis.
CASE PRESENTATION
A 62-year-old woman presented to her general
practitioner with fatigue, headache and itching over
a period of 6 weeks. There was no history of fever,
jaundice or weight loss. She was treated for otitis
externa with erythromycin 2 weeks before her pres-
entation. Routine bloods tests showed elevated
serum creatinine at 285 mmol/L (estimated glom-
erular ﬁltration rate (eGFR) 16 mL/min/1.73 m2).
Her serum creatinine was 56 mmol/L
(eGFR>60 mL/min/1.73 m2) 5 months prior to her
presentation, for summary of her laboratory investi-
gations see table 1.
Medical history included: hypertension, anxiety,
depression, hysterectomy, cholecystectomy and
herpes zoster infection. Her medications included:
hormonal replacement patches, bendroﬂumethia-
zide 2.5 mg once daily and venlafaxine 75 mg once
daily. She was a non-smoker and her alcohol con-
sumption was <2 units per week.
INVESTIGATIONS
The patient was admitted to the renal unit for
further assessment and consideration of performing
a renal biopsy. Abdominal examination revealed
splenomegaly. There was no evidence of generalised
lymphadenopathy.
The urine dipstick was bland on multiple occa-
sions. Chest X-ray was normal. Abdominal ultra-
sound conﬁrmed splenomegaly (17 cm) with
normal-size kidneys. Serum protein electrophoresis
and immunoﬁxation showed IgM band at a level of
8.58 g/L (normal range 0.5–3 g/L).
A signiﬁcant degree of ﬂuctuation in serum cre-
atinine was noted following her hospitalisation
(ﬁgure 1).
This ﬂuctuating pattern along with normal urea
concentration raised suspicion about the validity of
serum creatinine measurement particularly with the
presence of paraproteinaemia.
To investigate this possibility further, serum cre-
atinine was measured using the picric acid Jaffé
method. Renal excretory function was also assessed
with Cr51 EDTA isotope GFR measurement. Serum
creatinine concentration was found to be 86 mmol/L
by the Jaffé method and it was consistent with the
Cr51 EDTA GFR result of 71 mL/min (table 2).
Taken together, these ﬁndings indicated that
serum creatinine was falsely elevated when mea-
sured with enzymatic assay due to the presence of
an interfering compound. IgM paraprotein was the
culprit substance in this case.
A bone marrow biopsy was performed and the
histology and immunohistochemistry ﬁndings were
in keeping with a diagnosis of low-grade B-cell
non-Hodgkin’s lymphoma.
TREATMENT, OUTCOME AND FOLLOW-UP
Patient was treated initially with combination of
rituximab and bendamustine. She developed an
allergic reaction to rituximab. She eventually com-
pleted ﬁve cycles of bendamustine with good
response. Postchemotherapy serum creatinine
returned to normal range, which also coincides
with paraprotein disappearance (ﬁgure 1).
DISCUSSION
It is important that clinicians are aware of limita-
tions of commonly used laboratory tests. Such
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knowledge aids in avoiding unnecessary and potentially invasive
investigation. In the UK, ∼25% of laboratories use an enzymatic
method to measure creatinine. In general, the enzymatic
method, although more expensive, is preferred over the kinetic
Jaffé assay as it is less affected by interferences such as bilirubin,
protein, glucose and ketones.1 However, in this case, we demon-
strate how an enzymatic creatinine method was subject to inter-
ference by IgM paraproteinaemia.
Paraproteins have been shown to artiﬁcially inﬂuence differ-
ent methodologies of automated assays, including nephelometry,
turbidimetry and immunoassays.2 3
Reports in the literature highlight cases where paraproteins
have been shown to interfere with various assays available on
the automated analysers, including calcium, bilirubin, chloride,
phosphate and glucose.3
In one case report, IgM test interference was observed using
Siemens Advia enzymatic assay but not Abbott Architect
method.4 Both assays are using similar enzymatic reactions but
differ in methods of hydrogen peroxide and chromogen
detection.
The mechanism behind this IgM paraprotein interference is
unclear.
Scott et al suggested that interference phenomenon might
depend on the variable region of the IgM monoclonal antibody.
Using Roche creatinine plus enzymatic method, they reported
that only one in ﬁve patients with IgM paraproteinaemia
showed a falsely elevated serum creatinine.5 An alternative
explanation is that the IgM paraprotein may form complexes
with the reagents and increase the turbidity of the sample inter-
fering with the absorbance measurement.6
In our case, the monoclonal IgM band associated with lym-
phoplasmacytoid lymphoma caused a false elevation in the
serum creatinine concentration when measured by Siemens
Advia enzymatic assay method. This method is based on the
enzymatic reaction where creatinine is converted to creatine by
the action of creatininase, to produce creatine and sarcosine.
Table 1 Patient laboratory results with corresponding reference
interval
Investigation Result Reference
Leukocytes (109/L) 6.4 4–10
Haemoglobin (g/L) 101 13–17
Erythrocyte cell volume (MCV) 92 82–99
Platelets (109/L) 225 140–400
Sodium (mmol/L) 133 133–146
Potassium (mmol/L) 3.5 3.5–4.8
Phosphate (mmol/L) 1.26 0.8–1.5
Urate (υmol/L) <30 140–360
Protein total (g/L) 72 60–80
Albumin (g/L) 36 35–50
IgA (g/L) 1.97 0.8–4.0
IgM (g/L) 8.58 0.5–3.0
IgG (g/L) 5.69 6.0–16
Paraprotein type IgM lambda
C3 (mg/dL) 112.0 90–180
C4 (mg/dL) <1.7 10–40
C reactive protein (mg/dL) 40 0–4
ANA Negative
ANCA
Anti-MPO (IU/mL) <0.1 Normal: 0.0–3.5
Anti-PR3 (IU/mL) 0.2 Normal: 0.0–2.0
Anti-GBM (U/mL) 1.0 Negative <7
ANA, anti-nuclear antibody; ANCA, anti-neutrophil cytoplasmic antibody; anti-GBM,
anti-glomerular basement membrane antibodies; anti-MPO, myeloperoxidase
antibodies; anti-PR3, anti-proteinase 3 antibodies.
Figure 1 Plasma levels of Creatinine and urea before and after treatment.
Table 2 Results obtained by three different methods arranged
over 48 hours
Method used Serum creatinine (mmol/L) eGFR
Siemens Advia enzymatic assay 412 10
Jaffé method 86 >60
Cr51 EDTA GFR 71 mL/min
eGFR, estimated glomerular filtration rate.
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The sarcosine is metabolised by sarcosine oxidase to produce
glycine, formaldehyde and hydrogen peroxide. The hydrogen
peroxide in the presence of peroxidase yields a blue pigment.
The creatinine concentration is calculated by measuring the
absorbance of the blue colour at 596/694 nm.
This case highlights the signiﬁcance of paraprotein interfer-
ence with commonly used laboratory test. We recommend con-
sidering this possibility when assessing individual with elevated
serum creatinine and detectable IgM paraprotein.
Learning points
▸ Paraproteinaemia should be considered as a cause of falsely
elevated serum creatinine concentration.
▸ Validity of any test should be questioned if results are
inconsistent or conﬂicting with the clinical condition of the
patient.
▸ Good communication between clinicians and laboratories is
crucial when investigating challenging cases like this.
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